Thrive Wealth Management, LLC Astrazeneca PLC Transaction History
Thrive Wealth Management, LLC
- $518 Million
- Q1 2025
A detailed history of Thrive Wealth Management, LLC transactions in Astrazeneca PLC stock. As of the latest transaction made, Thrive Wealth Management, LLC holds 4,135 shares of AZN stock, worth $285,108. This represents 0.06% of its overall portfolio holdings.
Number of Shares
4,135
Previous 3,834
7.85%
Holding current value
$285,108
Previous $251,000
20.72%
% of portfolio
0.06%
Previous 0.05%
Shares
8 transactions
Others Institutions Holding AZN
# of Institutions
1,408Shares Held
512MCall Options Held
6.95MPut Options Held
2.95M-
Price T Rowe Associates Inc Baltimore, MD57.1MShares$3.94 Billion0.52% of portfolio
-
Primecap Management CO Pasadena, CA40.7MShares$2.8 Billion2.53% of portfolio
-
Wellington Management Group LLP Boston, MA35.6MShares$2.46 Billion0.52% of portfolio
-
Capital International Investors Los Angeles, CA31.3MShares$2.16 Billion0.47% of portfolio
-
Bank Of America Corp Charlotte, NC24MShares$1.66 Billion0.13% of portfolio
About ASTRAZENECA PLC
- Ticker AZN
- Exchange OTC
- Sector Healthcare
- Industry Drug Manufacturers—General
- Shares Outstandng 3,099,020,032
- Market Cap $214B
- Description
- AstraZeneca PLC, a biopharmaceutical company, focuses on the discovery, development, manufacturing, and commercialization of prescription medicines. Its marketed products include Calquence, Enhertu, Faslodex, Imfinzi, Iressa, Koselugo, Lumoxiti, Lynparza, Orpathys, Tagrisso, and Zoladex for oncology; Brilinta/Brilique, Bydureon/Byetta, BCise, By...